Académique Documents
Professionnel Documents
Culture Documents
ORIGINAL ARTICLE
The presence of large spontaneous splenorenal shunts (SSRSs) is a risk factor for poor portal vein ow and liver dysfunction. The disconnection of splenorenal shunts by left renal vein (LRV) ligation has been suggested as a potential solution for
improving portal ow. We reviewed the hemodynamic consequences of splenorenal shunts in deceased donor liver transplantation and investigated the role of LRV ligation. In 10 patients who underwent liver transplantation at our institution
between January 2006 and April 2010, an SSRS was diagnosed preoperatively. Intraoperative portal and hepatic artery
ows were measured with a transit time owmeter. The shunt was disconnected in 6 patients for whom the portal ow after
reperfusion was less than or equal to 1200 mL/minute. LRV ligation resulted in signicant increases in the portal ow. There
were no differences in renal function for the patients who underwent renal vein ligation and the patients who did not
undergo ligation. In conclusion, LRV ligation disconnects splenorenal shunts and modulates the portal inow without any
detrimental effects on renal function. Liver Transpl 17:891-895, 2011. V 2011 AASLD.
C
Abbreviations: ALD, alcoholic liver disease; CT, computed tomography; DBD, donation after brain death; DCD, donation after cardiac death; HA, hepatic artery; HCV, hepatitis C virus; IVC, inferior vena cava; LRV, left renal vein; MELD, Model for End-Stage
Liver Disease; PBC, primary biliary cirrhosis; PV, portal vein; SSRS, spontaneous splenorenal shunt.
This article was presented at the 16th Annual International Congress of the International Liver Transplantation Society
(Hong Kong, 2010).
Address reprint requests to Ernest Hidalgo, M.D., Ph.D., FRCS Ed., Scottish Liver Transplant Unit, Royal Inrmary of Edinburgh, 51 Old
Dalkeith Road, Edinburgh, United Kingdom EH14 4SA. E-mail: ernest.hidalgo@luht.scot.nhs.uk
DOI 10.1002/lt.22304
View this article online at wileyonlinelibrary.com.
LIVER TRANSPLANTATION.DOI 10.1002/lt. Published on behalf of the American Association for the Study of Liver Diseases
No
HCV
18
Complete
ALD
16
No
PBC
29
No
ALD
12
No
ALD
13
No
ALD
14
No
ALD
23
Complete
Cryptogenic
9
No
ALD
10
Partial
Autoimmune
19
65
DCD
Whole
45
DBD
Whole
65
DBD
Whole
66
DBD
Whole
61
DBD
Whole
51
DBD
Whole
57
DBD
Whole
55
DBD
Split
67
DBD
Whole
Patient 6
Patient 5
Patient 4
Patient 3
Patient 2
55
DBD
Whole
RESULTS
Patient 1
routine Doppler ultrasound and triple-phase abdominal computed tomography (CT) examinations. CT
scanning was performed with a Toshiba Aquilion 16
CT scanner (a 1-mm slice thickness was used for
reconstruction of the arterial and venous phases). The
contrast agent Omnipaque (300 mL) was used. The
degree of collateralization and the presence of SSRSs
were determined during the portal venous phase of
the scan (60 seconds after the contrast injection;
Fig. 1); an SSRS was dened as a communication
with a diameter greater than 1 cm. The main
demographic data are shown in Table 1. The latest
follow-up data were recorded by August 1, 2010.
Institutional Review Board approval is not required.
Nine patients received a full graft, and 1 patient
received a split graft [an extended right lobe with segments I and IV-VIII, the main PV, the right HA, and the
entire inferior vena cava (IVC), including the middle and
right hepatic veins, with a graft-to-recipient weight ratio
of 1.6]. One graft was from a donation after cardiac
death (DCD) donor. We measured native and postreperfusion ows in the HA, PV, and portocaval shunt with a
transit time owmeter (MediStim, Oslo, Norway). PV
and HA measurements were obtained and recorded for
a non-SSRS cohort of 100 adult liver transplant recipients. The mean PV ow before the abdomen was closed
was 1740 mL/minute, with only 10% of the cases having a ow less than or equal to 1200 mL/minute. The
mean HA ow in these patients was 262 mL/minute.
On the basis of these data and presumptive physiological data,17-19 the LRV was ligated when the PV ow after
reperfusion was less than or equal to 1200 mL/minute.
Patient 7
CT image of an SSRS.
Figure 1.
Patient 8
Patient 9
Patient 10
Recipient
age (years)
Type of donor
Type of graft
Pretransplant
PV thrombosis
Indication
MELD score
Hepatopulmonary
syndrome
Encephalopathy
*LRV ligation.
Not obtained.
2000
Yes
2500
Yes
1990
No
1670
Partial
Patient 3
2331
Yes
1024
No
Patient 4
3460
No
1560
No
Patient 5
2110
No
1370
No
Patient 6
1245
Yes
837
No
Patient 7
254
160
98
Patient 5
480
Patient 4*
120
Patient 3
120
180
Patient 6
175
440
Patient 7*
120
Patient 9
1390
No
1400
Complete
314
255
Patient 9
1400
Yes
1200
No
Patient 8
Patient 8*
300
Patient 2
Complete
No
Patient 1
Pretransplant PV thrombosis
PV ow after
reperfusion (mL/minute)
PV ow after reperfusion with
LRV clamping (mL/minute)
LRV ligation
243
300
Patient 10*
2350
Yes
1200
No
Patient 10
175
289
Mean
2077
6/10
1173
Mean
DISCUSSION
Patients with chronic liver disease develop portal
hypertension, which opens portocaval communications such as SSRSs. The incidence of radiologically
diagnosed SRSSs in our group was 3.8%, although a
much higher incidence has been reported in patients
with cirrhosis.20
In this series, the presence of an SSRS was almost
invariably associated with a reduction in the PV ow.
Furthermore, 3 of the 10 patients had PV thrombosis
(which was complete for 2 patients).
An almost 2-fold increase was noted when the
shunt was occluded by LRV clamping. This effect was
reversible. When HA measurements were carried out,
the increase in the PV ow was followed by a reduc-
ACKNOWLEDGMENTS
We acknowledge that this is a small, uncontrolled case
series and that a further evaluation of LRV ligation,
ideally in a randomized study, should be undertaken.
This study does suggest, however, that LRV ligation is
safe and produces an increase in the PV ow. We were
able to restore physiological PV ows and avoid potential complications due to poor portal ows (particularly
PV thrombosis). Although this does not translate into a
different transplant outcome, further studies of hemodynamics in deceased liver transplantation and the
implications for long-term outcomes are warranted.
REFERENCES
1. Bosch J, Pizcueta P, Feu F, Fernandez M, Garcia-Pagan
JC. Pathophysiology of portal hypertension. Gastroenterol Clin North Am 1992;21:1-13.
2. Bosch J, Navasa M, Garcia-Pagan JC, DeLacy AM, Rodes
J. Portal hypertension. Med Clin North Am 1989;73:
931-953.
3. De Carlis L, Del Favero E, Rondinara G, Belli LS, Sansalone CV, Zani B, et al. The role of spontaneous portosystemic shunts in the course of orthotopic liver
transplantation. Transpl Int 1992;5:9-14.
4. Rousselot LM, Moreno AH, Panke WF. Studies on portal
hypertension. IV. The clinical and physiopathologic signicance of self-established (nonsurgical) portal systemic
venous shunts. Ann Surg 1959;150:384-412.
5. Kita Y, Harihara Y, Sano K, Hirata M, Kubota K,
Takayama T, et al. Reversible hepatofugal portal ow after liver transplantation using a small-for-size graft from
a living donor. Transpl Int 2001;14:217-222.
6. Sekido H, Matsuo K, Takeda K, Morioka D, Kubota T,
Tanaka K, et al. Severe fatty change of the graft liver
caused by a portosystemic shunt of mesenteric varices.
Transpl Int 2002;15:259-262.
7. Fujimoto M, Moriyasu F, Nada T, Suginoshita Y, Ito Y,
Nishikawa K, et al. Inuence of spontaneous portosystemic collateral pathways on portal hemodynamics in living-related liver transplantation in children. Doppler
ultrasonographic study. Transplantation 1995;60:41-45.
8. Margarit C, Lazaro JL, Charco R, Hidalgo E, Revhaug A,
Murio E. Liver transplantation in patients with
9.
10.
11.
12.
13.
14.
15.
16.
17.